title: Modulation of the T cell compartment by blood transfusion. Effect on cytotoxic and helper T lymphocyte precursor frequencies and T cell receptor Vbeta usage.
abstract: Recent data suggest that the favorable effect of pretransplant blood transfusion (BT) on transplant outcome depends on the HLA match. HLA-DR or haplotype shared transfusions lead to transplantation tolerance, and HLA-mismatched BT leads to immunization. The immunological mechanism involved is still unknown. To investigate the effect of HLA compatibility between blood donor and recipient on the T cell compartment, we determined the frequency of cytotoxic and helper T cell precursors specific for blood donor cells (n=20) and the T cell receptor Vbeta (TCRBV) repertoire of the CD4- and CD8-positive peripheral blood mononuclear cells before, at 2 weeks after, and at more than 10 weeks after BT (n=10). Patients had received one transfusion of a nonstored (<24 hr after withdrawal) erythrocyte concentrate without buffy coat containing on average 6x10(8) leukocytes. Eight patients shared an HLA-B and -DR antigen, nine patients shared one HLA-DR antigen, and three patients shared no HLA class II antigens with the blood donor. All patients showed a significant increase in both cytotoxic and helper T cell precursor frequencies against the blood donor 2 weeks after BT. In most patients, the frequencies reached pretransfusion levels again long after BT. In 5 of 10 patients, an expansion of one or more TCRBV families was observed in either the CD4 or CD8 compartment. This study demonstrates that BT, irrespective of the degree of HLA matching, induces activation of the T cell compartment. The degree of sharing of HLA antigens was not correlated with quantitative changes in cytotoxic T lymphocyte precursor or helper T lymphocyte precursor frequencies, or changes induced in the TCRBV repertoire. Cytotoxic and helper T lymphocyte precursor frequencies and TCRBV repertoire determined after BT do not give an indication for a state of tolerance prior to transplantation.
authors.affiliation: Department of Immunohematology and Blood Bank, University Hospital Leiden, The Netherlands.
authors.forename: B J
authors.initials: BJ
authors.lastname: van der Mast
authors.forename: H E
authors.initials: HE
authors.lastname: Viëtor
authors.forename: E M
authors.initials: EM
authors.lastname: van der Meer-Prins
authors.forename: S P
authors.initials: SP
authors.lastname: van Bree
authors.forename: A
authors.initials: A
authors.lastname: Brand
authors.forename: P J
authors.initials: PJ
authors.lastname: van den Elsen
authors.forename: F H
authors.initials: FH
authors.lastname: Claas
mesh_terms: D001782:Blood Donors; D001788:Blood Grouping and Crossmatching; D001803:Blood Transfusion; D016827:CD8 Antigens / Q000276:immunology; D005802:Genes, MHC Class II / Q000502:physiology; D006684:HLA-DR Antigens / Q000494:pharmacology; D006801:Humans; D007518:Isoantibodies / Q000494:pharmacology; D018655:Lymphocyte Count / Q000187:drug effects; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics / Q000276:immunology; D013234:Stem Cells / Q000166:cytology; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000166:cytology; D006377:T-Lymphocytes, Helper-Inducer / Q000166:cytology
chemical_list: D016827:CD8 Antigens; D006684:HLA-DR Antigens; D007518:Isoantibodies; D016693:Receptors, Antigen, T-Cell, alpha-beta